Suppression of virus burden by immunization with feline immunodeficiency virus Env protein

Vaccine

Volumn 14, Issue 5, 1996, Pages 405-411

  Hosie, Margaret J ^a   Dunsford, Thomas H ^a   De Ronde, Anthony ^b   Willett, Brian J ^a   Cannon, Celia A ^a   Neil, James C ^a   Jarrett, Oswald ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

FIV; gp120; Vaccination

Indexed keywords

VIRUS ENVELOPE PROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CAT; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; IMMUNIZATION; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE;

EID: 0029876614     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00193-5     Document Type: Article

References (31)

1. Pedersen, N.C., Ho, E.M., Brown, M.L. and Yamamoto, J.K. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 1987, 235, 790-793
2. Hosie, M.J., Robertson, C. and Jarrett, O. Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus in cats in the United Kingdom. Vet. Rec. 1989, 125, 293-297
3. Ackley, C.D., Yamamoto, J.K., Levy, N., Pedersen, N.C. and Cooper, M.D. Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J. Virol. 1990, 64, 5652-5675
4. Hoffman-Fezer, G., Thum, J., Ackley, C. et al. Decline in CD4+ numbers in cats with naturally acquired feline immunodeficiency virus infection. J. Virol. 1982, 66, 1484-1488
5. Rigby, M.A., Holmes, E.C., Pistello, M. et al. Evolution of structural proteins of feline immunodeficiency virus: molecular epidemiology and evidence of selection for change. J. Gen. Virol. 1993, 74, 425-436
6. Sodora, D., Shpaer, E., Kitchell, B., Dow, S., Hoover, E. and Mullins, J. Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. J. Virol. 1994, 68, 2230-2238
7. Yamamoto, J.K., Okuda, T., Ackley, C.D. et al. Experimental vaccine protection against feline immunodeficiency virus. AIDS Res. Hum. Retroviruses 1991, 7, 911-921
8. Yamamoto, J.K., Hohdatsu, T., Olmsted, R.A. et al. Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus. J. Virol. 1993, 67, 601-605
9. Hosie, M., Osborne, R., Yamamoto, J.K., Neil, J.C. and Jarrett, O. Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines. J. Virol. 1995, 69, 1253-1255
10. Hosie, M.J. The development of a vaccine against feline immunodeficiency virus: a review. Br. Vet J. 1994, 150, 25-39
11. Yamamoto, J.K., Ackley, C.D., Zochlinski, H. et al. Development of IL-2-independent feline lymphoid cell lines chronically infected with feline immunodeficiency viruses: importance for diagnostic reagents and vaccines. Intervirology 1991, 32, 361-375
12. Johnson, C., Torres, B., Koyama, H. and Yamamoto, J.K. FIV as a model for AIDS vaccination. AIDS Res. Hum. Retroviruses 1994, 10, 225-228
13. Stott, E.J. Anti-cell antibody in macaques. Nature 1991, 353, 393
14. Chan, W.L., Rodgers, A., Hancock, R.D. et al. Protection in simian immunodeficiency virus-vaccinated monkeys correlates with anti-HLA class I antibody response. J. Exp. Med. 1992, 76, 1203-1207
15. Hohdatsu, T., Pu, R., Torres, B.A., Trujillo, S., Gardner, M.B. and Yamamoto, J.K. Passive antibody protection of cats against feline immunodeficiency virus infection. J. Virol. 1993, 67, 2344-2348
16. Osborne, R., Rigby, M., Siebelink, K., Neil, J.C. and Jarrett, O. virus neutralization reveals antigenic variation among feline immunodeficiency virus isolates. J. Gen. Virol. 1994, 75, 3641-3645
17. Lombardi, S., Garzelli, C., La Rosa, C. et al. Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelope. J. Virol. 1993, 67, 4742-4749
18. de Ronde, A., Stam, J.G., Boers, P. et al. Antibody response in cats to the envelope proteins of feline immunodeficiency virus: identification of an immunodominant neutralization domain. Virology 1993, 198, 1-8
19. Avrameas, A., Guillet, J.-G., Chouchane, L., Moraillon, A., Sonigo, P. and Strosberg, A.D. Localisation of three epitopes of the env protein of feline immunodeficiency virus. Mol. Immunol. 1992, 29, 565-572
20. Flynn, J.N., Cannon, C.A., Beatty, J. et al. Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo, with carrier-free synthetic peptide. J. Virol. 1994, 68, 5835-5844
21. Tamalet, C., Lafeuillade, A., Yahi, N. et al. Comparison of viral burden and phenotype of HIV-1 isolates from lymph nodes and blood. AIDS 1994, 8, 1083-1088
22. Willett, B.J., Hosie, M.J., Dunsford, T., Neil, J.C. and Jarrett, O. Productive infection of helper T lymphocytes with FIV is accompanied by reduced expression of CD4. AIDS 1991, 5, 1469-1475
23. Willett, B.J., Hosie, M.J., Neil, J.C. and Jarrett, O. Early expansion of a CD8+ subset follows infection with FIV. Immunology 1993, 78, 1-6
24. Israel, Z.R., Edmonson, P.F., Maul, D.H. et al. Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines. J. Virol. 1994, 68, 1843-1853
25. Schafferman, A., Jahrling, P.B., Benveniste, R.E. et al. Protection of macaques with a simian immunodeficiency is virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences. Proc. Natl Acad. Sci. USA 1991, 88, 7126-7130
26. Flynn, J.N., Beatty, J.A., Cannon, C.A. et al. Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus. AIDS Res. Hum. Retroviruses 1995, 11, 1107-1113
27. Hosie, M.J., Osborne, R., Reid, G., Neil, J.C. and Jarrett, O. Enhancement after feline immunodeficiency virus vaccination. Vet. Immunol. Immunopathol. 1992, 35, 191-198
28. Lombardi, S., Garzelli, C., Pistello, M. et al. A neutralising antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity. J. Virol. 1994, 68, 8374-8379
29. Siebelink, K.H.J., Tijhaar, E., Huisman, R.C. et al. Enhancement of feline immunodeficiency virus infection after immunisation with envelope glycoprotein subunit vaccines. J. Virol. 1995, 69, 3704-3711
30. Baldinotti, F., Matteucci, D., Mazzetti, P. et al. Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system. J. Virol. 1994, 68, 4572-4579
31. Sawyer, L.S.W., Wrin, M.T., Crawford-Miksza, L. et al. Neutralisation sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated. J. Virol. 1994, 68, 1342-1349